Partnerships
Structured Deals on the Rise: Milestones, Options, and Risk-Sharing in Biopharma Licensing
David Alvaro, Ph.D.
Pharma's Almanac
PAO-01-26-NI-04Jan 8, 2026
Patented Production Strains
Adding Value with Patent Protection for Novel, Tailor-Made Bacterial Production Strains
Trond Erik Vee Aune, Ph.D.
Vectron Biosolutions
PAO-08-022-CL-03Aug 16, 2022
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
Hovione
PR-M05-22-04May 9, 2022
License Agreement
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of RSV Vaccine for Adults in China
Nuance Pharma
PR-M03-22-08Mar 21, 2022
License Agreement
Confirmation That the License to Develop Oral Vaccine Delivery Platform Has Been Executed
Poolbeg Pharma PLC
PR-M01-22-22Jan 31, 2022
Licensing
Corbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic Diseases
Corbus
PR-M06-21-009Jun 7, 2021
Licensing Agreement
Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder
Massachusetts Eye and Ear
PR-M07-20-NI-001Jul 3, 2020
Agreement
Hansa Biopharma Announces Exclusive Agreement with Sarepta Therapeutics to Develop Imlifidase as Pre-treatment Ahead of Gene Therapy
Sarepta Therapeutics, Inc
PR-M07-20-NI-004Jul 3, 2020
Licensing
AstraZeneca Completes Recovery of Global Rights to Brazikumab from Allergan
AstraZeneca
PR-M05-20-NI-019May 14, 2020
Licensing
LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate
LEO Pharma
PR-M04-20-NI-023Apr 15, 2020
Licensing
Facilitating Pharma Licensing and Partnering
Erica Sosnowski; Adam Sosnowski
Sosna & Co.
PAP-Q1-20-CL-026Mar 19, 2020
Legality
Legal Issues in Licensing and M&A
Randy Sunberg
Baker McKenzie
PAP-Q1-20-CL-028Mar 19, 2020
License Agreement
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor
SeraNovo
PR-M10-19-NI-046Oct 30, 2019
Licensing Agreement
Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy Akcea-ANGPTL3-LRX
Pfizer
PR-M10-19-NI-020Oct 11, 2019
Licensing
Ionis Licenses Hepatitis B Program to GSK
Ionis Pharmaceuticals, Inc.
PR-M08-19-NI-085Aug 29, 2019
License Agreement
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss
Astellas
PR-M07-19-NI-055Jul 22, 2019
Licensing
Prestige Biopharma and Pharmapark Announce License and Supply Agreement to Commercialize Prestige's Trastuzumab Biosimilar in the Russian Federation
Prestige Biologics
PR-M07-19-NI-021Jul 9, 2019
Licensing
Harbour BioMed Enters Multi-Year HCAb Technology Licensing Agreement with a Top-Ten Global Pharma for Next Generation Human Antibody Discovery
Harbour BioMed
PR-M05-19-NI-088May 31, 2019
Collaboration
Lilly and ImmuNext Announce Licensing and Research Collaboration
Eli Lilly and Company
PR-M03-19-NI-086Mar 29, 2019
Immuno-Oncology
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million
WuXi Biologics
PR-M02-19-NI-067Feb 28, 2019